ArticleBMC cardiovascular disorders2026
Predictive value of the C-reactive protein-triglyceride-glucose index for late atrial fibrillation recurrence after radiofrequency catheter ablation: a retrospective cohort study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe C-reactive protein-triglyceride-glucose index (CTI) has been reported to be positively associated with cardiovascular disease, stroke, and other adverse outcomes. However, the association between CTI and late atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) has not been well established.
methodsA total of 591 patients with AF who underwent RFCA were retrospectively enrolled. CTI was calculated using triglycerides, fasting plasma glucose, and C-reactive protein. The primary endpoint was late AF recurrence during postoperative follow-up. The association between CTI and late AF recurrence after RFCA was assessed using restricted cubic spline (RCS) analysis and univariate and multivariable logistic regression analyses. Receiver operating characteristic curve analysis and the DeLong test were conducted to assess the predictive performance of CTI. Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were adopted to evaluate its incremental predictive value. The Hosmer-Lemeshow test and Bootstrap-calibrated curves were used to verify model calibration and goodness-of-fit. Subgroup analyses were conducted to examine potential variations in the association between CTI and AF recurrence across subgroups. Subgroup analyses were conducted to examine potential variations in the association between CTI and AF recurrence across subgroups.
resultsAll patients were followed for 1 year postoperatively, during which 92 cases of AF recurrence were documented. Higher CTI levels were positively associated with an increased risk of AF recurrence. RCS analysis suggested that the nonlinear test did not reach statistical significance (p for non-linear = 0.072), while a trend toward nonlinearity was observed, which may be explained by the limited number of outcome events. After multivariable adjustment, CTI remained independently and positively associated with AF recurrence, with an odds ratio of 6.20 per one-unit increase in CTI (95% CI: 3.56-10.77; p < 0.001). Subgroup and interaction analyses yielded findings consistent with the primary results.
conclusionsCTI was identified as a potentially valuable predictive indicator for late AF recurrence following RFCA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.